Andexanet Alfa (Andexxa) Withdrawn from U.S. Market: What Patients Need to Know

by Christopher R. LoPalo, Partner AstraZeneca has withdrawn Andexxa (andexanet alfa) from the United States market effective December 22, 2025. Patients who experienced adverse health outcomes, complications, or...

Lesen Sie den Artikel

PFAS in Biosolids: 2025 Statehouses Take the Lead

For PFAS in biosolids, 2025 was the year statehouses stepped decisively into the vacuum. While federal policy is evolving, state and local governments are rapidly redrawing the rules...

Lesen Sie den Artikel

Suspected Birth Injury? What Parents Need to Know and Do Next

Bringing a baby into the world is supposed to be joyful. When something goes wrong during pregnancy, labor, or delivery, that joy can be replaced in an instant...

Lesen Sie den Artikel